Pharmaceutical companies heavily rely on patents as their main vehicle to protect intellectual property.
May 14, 2021 8:58AM
August 31, 2018 9:54AM
Ottawa’s changes may delay the launch of new innovative medications in Canada.
July 20, 2018 1:00AM
February 15, 2006 2:00AM
Price Controls, Patents, and Cross-Border Internet Pharmacies: Risks to Canada's Drug Supply and International Trading Relations
July 17, 2003 2:00AM
Before breaking for the summer, the House of Commons Standing Committee on Industry, Science, and Technology considered weakening the patent regulations that support Canadas pharmaceutical market. Now, prompted by public-sector unions, the Competition Bureau will look at whether pharmaceutical patents are anti-competitive. These investigations have only one result: to harm international investors confidence in Canadas will to protect intellectual property. Furthermore, history suggests that if they succeed in weakening patents, drug costs are unlikely to come down.